Acetyl-L-Carnitine In Severe Hepatic Encephalopathy

Summary

To assess the clinical efficacy of ALC in the treatment of severe hepatic encephalopathy (grade 3 of the West Haven grading scale), we performed a randomised, double blind placebo-controlled study administering ALC to cirrhotic patients, evaluating the effects on ammonia levels and performance in cognitive functions.

Timeline

Start

2002-07

Primary completion

—

Completion

2005-12

Drugs

Indications